![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Autoimmune Disorders |
Free Subscription
1 Ann Neurol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Autoimmune Disorders is free of charge.
ZSCAN1 autoantibodies are associated with pediatric paraneoplastic ROHHAD.
Ann Neurol. 2022 Apr 25. doi: 10.1002/ana.26380.
PubMed
Abstract available
Anti-N-methyl-D-aspartate receptor encephalitis associated with chronic
myelogenous leukemia, causality or coincidence? A case report.
BMC Neurol. 2022;22:153.
PubMed
Abstract available
Outcomes of patients presenting with Guillain-Barre Syndrome at a tertiary care
center in India.
BMC Neurol. 2022;22:151.
PubMed
Abstract available
Fatigue, stigma, and mood in patients with multiple sclerosis: effectiveness of
guided imagery.
BMC Neurol. 2022;22:152.
PubMed
Abstract available
The Amphiregulin/EGFR axis protects from lupus nephritis via downregulation of
pathogenic CD4(+) T helper cell responses.
J Autoimmun. 2022;129:102829.
PubMed
Abstract available
Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac)
COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated
people in Hong Kong.
J Autoimmun. 2022;130:102830.
PubMed
Abstract available
Integration of Infant Metabolite, Genetic and Islet Autoimmunity Signatures to
Predict Type 1 Diabetes by 6 Years of Age.
J Clin Endocrinol Metab. 2022 Apr 25. pii: 6573923. doi: 10.1210.
PubMed
Abstract available
Restoration of Follicular T-Regulatory/Helper Cell Balance by OX40L-JAG1
Cotreatment Suppresses Lupus Nephritis in NZBWF1/j Mice.
J Immunol. 2022 Apr 25. pii: jimmunol.2200057. doi: 10.4049/jimmunol.2200057.
PubMed
Abstract available
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: an
entity associated with distinct diseases and comparison between IgG1 and IgG3
subtypes.
J Nephrol. 2022 Apr 23. pii: 10.1007/s40620-022-01317.
PubMed
Abstract available
Serum cytokine and chemokine profiles in patients with immune-mediated
necrotizing myopathy.
J Neuroimmunol. 2022;365:577833.
PubMed
Abstract available
Virus-specific antibody indices may supplement the total IgG index in diagnostics
of multiple sclerosis.
J Neuroimmunol. 2022;367:577868.
PubMed
Abstract available
Objectively assessed physiological, physical, and cognitive function along with
patient-reported outcomes during the first 2 years of Alemtuzumab treatment in
multiple sclerosis: a prospective observational study.
J Neurol. 2022 Apr 28. pii: 10.1007/s00415-022-11134.
PubMed
Abstract available
Musculoskeletal Diagnoses before Cancer in Children: A Danish Registry-Based
Cohort Study.
J Pediatr. 2022;242:32-38.
PubMed
Abstract available
The Periorbital Rash of Neonatal Lupus.
J Pediatr. 2021 Dec 2. pii: S0022-3476(21)01162.
PubMed
Acute glomerulonephritis.
Lancet. 2022;399:1646-1663.
PubMed
Abstract available
Comparison of switching to 6-week dosing of natalizumab versus continuing with
4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a
randomised, controlled, open-label, phase 3b trial.
Lancet Neurol. 2022 Apr 25. pii: S1474-4422(22)00143.
PubMed
Abstract available
Natalizumab for multiple sclerosis: the dilemma of NOVA.
Lancet Neurol. 2022 Apr 25. pii: S1474-4422(22)00170.
PubMed
Effects of teriflunomide treatment on cognitive performance and brain volume in
patients with relapsing multiple sclerosis: Post hoc analysis of the TEMSO core
and extension studies.
Mult Scler. 2022 Apr 29:13524585221089534. doi: 10.1177/13524585221089534.
PubMed
Abstract available
Corpus callosum damage to account for cognitive, affective, and social-cognitive
dysfunctions in multiple sclerosis: A model of callosal disconnection syndrome?
Mult Scler. 2022 Apr 27:13524585221091067. doi: 10.1177/13524585221091067.
PubMed
Abstract available
Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in
multiple sclerosis: An observational study.
Mult Scler. 2022 Apr 27:13524585221092309. doi: 10.1177/13524585221092309.
PubMed
Abstract available
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in
patients with multiple sclerosis and other autoimmune diseases?
Mult Scler. 2022 Apr 27:13524585221089540. doi: 10.1177/13524585221089540.
PubMed
Abstract available
Experience with tocilizumab in patients with neuromyelitis optica spectrum
disorders.
Neurologia (Engl Ed). 2022;37:178-183.
PubMed
Abstract available
Current evidence on the potential therapeutic applications of transcranial
magnetic stimulation in multiple sclerosis: a systematic review of the
literature.
Neurologia (Engl Ed). 2022;37:199-215.
PubMed
Abstract available
Cancer Screening in Patients With Multiple Sclerosis: Are We Doing Enough?
Neurology. 2022 Apr 28. pii: WNL.0000000000200366.
PubMed
Multiple Sclerosis Incidence in Black Patients: It's Time to Do Away With a
Racial Medical Myth.
Neurology. 2022 Apr 28. pii: WNL.0000000000200309.
PubMed
Racial and Ethnic Disparities in Multiple Sclerosis Prevalence.
Neurology. 2022 Apr 28. pii: WNL.0000000000200151.
PubMed
Abstract available
Multiple Sclerosis and the Cancer Diagnosis: Diagnostic Route, Cancer Stage, and
the Diagnostic Interval in Breast and Colorectal Cancer.
Neurology. 2022 Apr 28. pii: WNL.0000000000200163.
PubMed
Abstract available
Association of No Evidence of Disease Activity With No Long-term Disability
Progression in Multiple Sclerosis: A Systematic Review and Meta-analysis.
Neurology. 2022 Apr 26. pii: WNL.0000000000200549.
PubMed
Abstract available
Advancing Care and Outcomes for African American Patients With Multiple
Sclerosis.
Neurology. 2022 Apr 25. pii: WNL.0000000000200791.
PubMed
Abstract available
School performance in Danish children exposed to maternal type 1 diabetes in
utero: A nationwide retrospective cohort study.
PLoS Med. 2022;19:e1003977.
PubMed
Abstract available
Exercise-induced increase in blood-based brain-derived neurotrophic factor (BDNF)
in people with multiple sclerosis: A systematic review and meta-analysis of
exercise intervention trials.
PLoS One. 2022;17:e0264557.
PubMed
Abstract available
Prediction of prognosis in immunoglobulin a nephropathy patients with focal
crescent by machine learning.
PLoS One. 2022;17:e0265017.
PubMed
Abstract available
Comparing actuarial and subjective healthy life expectancy estimates: A
cross-sectional survey among the general population in Hungary.
PLoS One. 2022;17:e0264708.
PubMed
Abstract available
Myasthenia gravis complement activity is independent of autoantibody titer and
disease severity.
PLoS One. 2022;17:e0264489.
PubMed
Abstract available
Real-world impact of primary immune thrombocytopenia and treatment with
thrombopoietin receptor agonists on quality of life based on patient-reported
experience: Results from a questionnaire conducted in Switzerland, Austria, and
Belgium.
PLoS One. 2022;17:e0267342.
PubMed
Abstract available
The safety and efficacy of fingolimod: Real-world data from a long-term,
non-interventional study on the treatment of RRMS patients spanning up to 5 years
from Hungary.
PLoS One. 2022;17:e0267346.
PubMed
Abstract available
Multiple sclerosis patients have an altered gut mycobiome and increased fungal to
bacterial richness.
PLoS One. 2022;17:e0264556.
PubMed
Abstract available
Correction to: Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients
with Graves' Orbitopathy by Vannucchi, et al. Thyroid 2021;31(5):821-828; doi:
10.1089/thy.2020.0269.
Thyroid. 2022 Apr 25. doi: 10.1089/thy.2020.0269.
PubMed
Immunophenotype of lacrimal glands in Graves orbitopathy: Implications for the
pathogenesis of Th1 and Th17 immunity.
Thyroid. 2022 Apr 25. doi: 10.1089/thy.2021.0671.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by